Interleukin-2 (IL-2) and granulocyte-macrophage stimulating factor (GM-CSF) for treatment of relapse after allogeneic stem cell transplant (ASCT)
C.R. Bachier, P. Shaughnessy, D. Wall, M. Grimley, C.F. LeMaistreVolume:
12
Year:
2006
Language:
english
DOI:
10.1016/j.bbmt.2005.11.176
File:
PDF, 68 KB
english, 2006